Intraparotid injection of bupivacaine with dexamethasone after partial parotidectomy
Official title: Evaluation of the Clinical Tolerance of an Intraparotid Injection of Bupivacaine, Combined With Dexamethasone, After Parotidectomy for Benign Tumor - A Single-center Prospective Cohort Study.
Run by Centre Hospitalier Universitaire de Nīmes · NCT07812259 · Data updated 2026-11-12
This early-phase study tests whether a single intraparotid injection of bupivacaine with dexamethasone is safe and tolerable after partial parotidectomy for a benign tumor.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Nīmes Academic / other |
| Locations | 1 site (Nîmes) |
| Status | Recruiting |
| Started | May 18, 2026 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT07812259 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults undergoing partial parotidectomy for benign parotid tumors who can provide informed consent and have appropriate health insurance.
✕Probably not a fit
Patients with contraindications to local amino-amide anesthetics, excessive comorbidities, or inability to consent may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This early phase1 trial investigates the safety and tolerability of a single intraparotid injection of bupivacaine combined with dexamethasone administered after partial parotidectomy for benign parotid tumors. The approach targets reducing postoperative saliva-related complications by providing prolonged local anesthesia and anti-inflammatory effects. Participants are adults with a surgical indication for partial parotidectomy who consent to participate and meet eligibility criteria. The study design is interventional; specific endpoints and procedures are described in the protocol. No comparator is stated at this phase, and results will inform feasibility and potential for larger studies.
Why it matters
Potential benefit: If successful, the approach could reduce postoperative salivary complications and improve comfort after partial parotidectomy.
How similar studies have gone: Previous similar approaches in this area are limited; this trial explores feasibility and safety in a novel single-injection strategy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Validated surgical indication for partial parotidectomy for parotid tumor. * The patient must have given their free and informed consent and signed the consent form * The patient must be a member or beneficiary of a health insurance plan Exclusion Criteria: * The subject is in a period of exclusion determined by a previous study * The patient is under safeguard of justice or state guardianship * History of allergic reaction to amino-amide-type local anesthetics. * Severe neurological history (epilepsy, peripheral neuropathies). * High-risk cardiovascular history (severe hypertension, arrhythmias, complete or incomplete heart block, heart failure, coronary artery disease, treatment with type 2 antiarrhythmic drugs). * Severe liver or kidney disease (severe liver failure or severe kidney failure). * Acidosis, sepsis. * Pregnant or breastfeeding patient. * Patient unable to give informed consent. * Patient for whom it is impossible to provide informed consent.
Where it's running
-
Centre Hospitalier de Nimes
Nîmes, France Recruiting
Study contacts
- Principal investigator: Benjamin Lallemant — Centre Hospitalier Universitaire de Nīmes
- Study coordinator: Benjamin Lallemant
- Email: benjamin.lallemant@chu-nimes.fr
- Phone: 04.66.68.36.85
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dexamethasone and Bupivacaine in a Shoulder Nerve Block: How It Affects Blood Levels
This study tests whether giving dexamethasone with a shoulder block affects the blood level of bupivacaine after a single injection.
-
Dexamethasone and Spinal Block Duration in Lower Abdominal Surgery
This study tests whether giving dexamethasone before spinal anesthesia can lengthen how long the numbness lasts for adults having lower abdominal surgery.
-
Olanzapine-based, dexamethasone-sparing antiemetic regimen for breast cancer patients with metabolic risk factors
This study tests whether an olanzapine-containing antiemetic plan can match the usual dexamethasone-containing approach in preventing delayed chemotherapy-induced nausea and vomiting for breast cancer patients with metabolic risk factors.
-
Liposomal Bupivacaine Plus Plain Bupivacaine vs Dexamethasone Plus Plain Bupivacaine for High-Risk Pain After Supraclavicular Brachial Plexus Block
This trial tests whether liposomal bupivacaine with plain bupivacaine can better control postoperative pain after distal radial fracture surgery in patients at high risk of severe pain, compared with dexamethasone plus plain bupivacaine.
-
Adding dexmedetomidine to spinal bupivacaine for pain relief during knee surgery
This trial tests whether small intrathecal doses of dexmedetomidine added to spinal bupivacaine can prolong pain relief after knee surgery in adult men.
-
Dexamethasone dosing for children with acute asthma in the emergency department
This study tests whether two different single doses of dexamethasone given in the emergency department help children aged 4–15 during an asthma attack.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.